{"id":356177,"date":"2026-11-20T09:26:57","date_gmt":"2026-11-20T03:56:57","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=356177"},"modified":"2026-11-20T09:26:57","modified_gmt":"2026-11-20T03:56:57","slug":"why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/","title":{"rendered":"Fredun Pharmaceuticals Ltd. (FREDUN) 52 Week High Streak: Second Straight Session"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/fredun\/fredun-pharmaceuticals-ltd-share-price-today\">Fredun Pharmaceuticals Ltd. (FREDUN)<\/a> share price reached a fresh 52-week high of Rs 1,730.8 today and later stood at Rs 1,718.3, up 0.62% from the previous close. Market cap was Rs 2,798.83 crore.<\/em><\/div>\n<div class=\"summary\">\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/fredun\/fredun-pharmaceuticals-ltd-share-price-today\">Fredun Pharmaceuticals Ltd.<\/a> has now set a fresh 52-week high for its second straight session, with the stock moving up 5.14% across the streak and touching Rs 1,730.8 in the latest move. The latest Univest figures confirm the repeated-high pattern, but they do not establish a company-specific catalyst for the continued rise.<\/p>\n<p style=\"margin-top:0!important;\">At 20 November 2026 at 9:22 AM IST, Fredun Pharmaceuticals Ltd. traded at Rs 1,718.3 versus the previous close of Rs 1,707.7. It opened at Rs 1,712 and moved between Rs 1,704.95 and Rs 1,730.8, with a market capitalisation of Rs 2,798.83 crore. For readers, a repeated 52 Week High Streak is more than a one-off breakout: it shows that the stock has printed fresh yearly highs on back-to-back sessions, while the current pattern remains a price fact rather than a confirmed business trigger.<\/p>\n<\/div>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Fredun_Pharmaceuticals_Ltd_52_Week_High_Streak_Consecutive_High_Analysis\" title=\"Fredun Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis\">Fredun Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#What_the_Repeated_52-Week_Highs_Show\" title=\"What the Repeated 52-Week Highs Show\">What the Repeated 52-Week Highs Show<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Fredun_Pharmaceuticals_Ltd_FREDUN_Fundamental_Analysis\" title=\"Fredun Pharmaceuticals Ltd. (FREDUN) Fundamental Analysis\">Fredun Pharmaceuticals Ltd. (FREDUN) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Why_Investors_Are_Watching_Fredun_Pharmaceuticals_Ltd\" title=\"Why Investors Are Watching Fredun Pharmaceuticals Ltd.\">Why Investors Are Watching Fredun Pharmaceuticals Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#About_Fredun_Pharmaceuticals_Ltd\" title=\"About Fredun Pharmaceuticals Ltd.\">About Fredun Pharmaceuticals Ltd.<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#What_is_Fredun_Pharmaceuticals_Ltd_52_Week_High_Streak\" title=\"What is Fredun Pharmaceuticals Ltd. 52 Week High Streak?\">What is Fredun Pharmaceuticals Ltd. 52 Week High Streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#For_how_many_sessions_has_Fredun_Pharmaceuticals_Ltd_set_a_fresh_52-week_high\" title=\"For how many sessions has Fredun Pharmaceuticals Ltd. set a fresh 52-week high?\">For how many sessions has Fredun Pharmaceuticals Ltd. set a fresh 52-week high?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#By_how_much_has_Fredun_Pharmaceuticals_Ltd_moved_across_the_streak\" title=\"By how much has Fredun Pharmaceuticals Ltd. moved across the streak?\">By how much has Fredun Pharmaceuticals Ltd. moved across the streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#What_is_the_latest_52-week_high_for_Fredun_Pharmaceuticals_Ltd\" title=\"What is the latest 52-week high for Fredun Pharmaceuticals Ltd.?\">What is the latest 52-week high for Fredun Pharmaceuticals Ltd.?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#How_did_Fredun_Pharmaceuticals_Ltd_trade_relative_to_the_previous_close\" title=\"How did Fredun Pharmaceuticals Ltd. trade relative to the previous close?\">How did Fredun Pharmaceuticals Ltd. trade relative to the previous close?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Is_there_a_confirmed_company-specific_catalyst_for_the_repeated_highs\" title=\"Is there a confirmed company-specific catalyst for the repeated highs?\">Is there a confirmed company-specific catalyst for the repeated highs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#How_is_Fredun_Pharmaceuticals_Ltd_valued_after_the_streak\" title=\"How is Fredun Pharmaceuticals Ltd. valued after the streak?\">How is Fredun Pharmaceuticals Ltd. valued after the streak?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#How_does_the_stock_compare_with_its_industry_medians\" title=\"How does the stock compare with its industry medians?\">How does the stock compare with its industry medians?<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-fredun-pharmaceuticals-ltd-share-52-week-consecutive-high-2026\/#Track_Fredun_Pharmaceuticals_Ltd_Share_Price_on_Univest\" title=\"Track Fredun Pharmaceuticals Ltd. Share Price on Univest\">Track Fredun Pharmaceuticals Ltd. Share Price on Univest<\/a><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Fredun_Pharmaceuticals_Ltd_52_Week_High_Streak_Consecutive_High_Analysis\"><\/span><strong>Fredun Pharmaceuticals Ltd. 52 Week High Streak: Consecutive High Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,718.3<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,707.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 10.6 (+0.62%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,712<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,730.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,704.95<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,798.83 crore<\/td>\n<\/tr>\n<\/table>\n<p>Fredun Pharmaceuticals Ltd. (FREDUN) traded at Rs 1,718.3 versus the previous close of Rs 1,707.7, a rise of 0.62%. The stock opened at Rs 1,712, reached a high of Rs 1,730.8 and touched a low of Rs 1,704.95.<\/p>\n<p>Fredun Pharmaceuticals Ltd. 52 Week High Streak starts with the intraday picture, because today\u2019s price action gives the immediate context for the second straight yearly high. The stock was last traded at Rs 1,718.3, up Rs 10.6 or 0.62% from the previous close of Rs 1,707.7. It opened at Rs 1,712, moved to a high of Rs 1,730.8 and a low of Rs 1,704.95, and the latest price stood near the upper end of that range as it touched the fresh peak. Market capitalisation stood at Rs 2,798.83 crore.<\/p>\n<p>For a Fredun Pharmaceuticals Ltd. 52 Week High Streak article, this is the core day-to-day read: the stock is not just above the previous close, it is also extending the one-year high sequence that began on the prior trading date. The current print is only one part of the picture, but it supports the broader pattern that the market has now marked a higher reference point on two consecutive sessions. That is the difference between a one-day breakout and a Fredun Pharmaceuticals Ltd. 52 Week High Streak.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"What_the_Repeated_52-Week_Highs_Show\"><\/span><strong>What the Repeated 52-Week Highs Show<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Fredun Pharmaceuticals Ltd. 52 Week High Streak matters because the stock has now set a fresh one-year high on both sessions in the current run, not just on one isolated day. The cumulative move across the streak is 5.14%, and the latest high of Rs 1,730.8 is also the current 52-week peak. The key point is simple: the repeated-high pattern is confirmed, while the reason behind it is not established by the price data alone.<\/p>\n<p>In a Fredun Pharmaceuticals Ltd. 52 Week High Streak, the most useful comparison is not just with the previous close, but with the earlier high reference. The stock has moved from the prior session\u2019s breakout level into a new higher peak, which means the one-year range has been reset twice in quick succession. That tells readers that the market has priced the stock at a new high twice, but it does not tell them why. The numerical record supports the pattern; it does not confirm a catalyst.<\/p>\n<p>For investors tracking a Fredun Pharmaceuticals Ltd. 52 Week High Streak, the right question is whether the company\u2019s earnings base and valuation base can support the newer price zone. Since the share price has moved higher while the business metrics below remain the same, the change in the multiples comes from price alone, not from any fresh revision in reported operating figures.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Fredun_Pharmaceuticals_Ltd_FREDUN_Fundamental_Analysis\"><\/span><strong>Fredun Pharmaceuticals Ltd. (FREDUN) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,798.83 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">55.22x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.44x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.09%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.34%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 30.93<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 202.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.01%<\/td>\n<\/tr>\n<\/table>\n<p>Fredun Pharmaceuticals Ltd. (FREDUN) fundamental metrics show P\/E 55.22x, P\/B 8.44x, ROE 16.09%, ROCE 21.34%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>Fredun Pharmaceuticals Ltd. has a market capitalisation of Rs 2,798.83 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 55.22x, P\/B at 8.44x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.09% and ROCE of 21.34%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 30.93, book value per share of Rs 202.35, dividend yield of 0.01%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P\/E of 30.75x, median ROE of 11.22%, median ROCE of 13.1%. Taken together, they outline the fundamentals rather than a view on the stock.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">55.22x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.75x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">59.39x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.73x to 1,399.41x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">8.44x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.84x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">16.09%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.22%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">21.34%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,798.83 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 766.63 crore<\/td>\n<\/tr>\n<\/table>\n<p>Fredun Pharmaceuticals Ltd. (FREDUN) operates in the Healthcare sector, within the Pharmaceuticals &amp; Drugs industry.<\/p>\n<p>Fredun Pharmaceuticals Ltd. (FREDUN) has a P\/E ratio of 55.22x, which is above the benchmark median of 30.75x, a difference of +79.58%. On its own, the P\/E gap is a valuation reference point, not a trading call.<\/p>\n<p>Fredun Pharmaceuticals Ltd. (FREDUN) has a ROE of 16.09%, which is above the benchmark median of 11.22%, a difference of +43.4%. Fredun Pharmaceuticals Ltd. (FREDUN) has a ROCE of 21.34%, which is above the benchmark median of 13.1%, a difference of +62.9%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/indswftlab\/ind-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Ind-Swift Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INDSWFTLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,968.06<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.47<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/advenzymes\/advanced-enzyme-technologies-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Advanced Enzyme Technologies Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ADVENZYMES<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,079.88<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.43<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/solara\/solara-active-pharma-sciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Solara Active Pharma Sciences Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SOLARA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,139.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">83.52<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2.15<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-0.63<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.61<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/unichemlab\/unichem-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Unichem Laboratories Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">UNICHEMLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3,400.95<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.81<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.68<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sakar\/sakar-healthcare-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sakar Healthcare Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAKAR<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,246.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">50.67<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.28<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.52<\/td>\n<\/tr>\n<\/table>\n<p>Fredun Pharmaceuticals Ltd. (FREDUN) has a P\/E ratio of 55.22x compared with the displayed peer median of 34.92x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 16.09% compares with a peer median of 9.81% across the companies shown in the table. ROCE stood at 21.34% versus the displayed peer median of 10.68%, providing a capital-efficiency comparison. Fredun Pharmaceuticals Ltd. (FREDUN) has a market capitalisation of Rs 2,798.83 crore. Among the 5 peers shown, 4 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Fredun_Pharmaceuticals_Ltd\"><\/span><strong>Why Investors Are Watching Fredun Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Fredun Pharmaceuticals Ltd. 52 Week High Streak has lasted two straight sessions, with a fresh yearly peak on each day.<\/li>\n<li>The cumulative move across the streak is 5.14%, which is the key multi-session number to track.<\/li>\n<li>The latest 52-week high is Rs 1,730.8, and that is the current high-water mark for the stock.<\/li>\n<li>The company\u2019s ROE of 16.09% and ROCE of 21.34% remain above the industry medians in the snapshot.<\/li>\n<li>The stock trades at 55.22 times earnings and 8.44 times book, which keeps valuation in focus after the streak.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Fredun_Pharmaceuticals_Ltd\"><\/span><strong>About Fredun Pharmaceuticals Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Fredun Pharmaceuticals Ltd. operates in the Pharmaceuticals &amp; Drugs industry within the Healthcare sector. For a Fredun Pharmaceuticals Ltd. 52 Week High Streak, the business context that matters most is its position as a mid-sized listed company with a market capitalisation of Rs 2,798.83 crore and return ratios above the same-industry median. That helps frame the streak without turning it into a broader company story.<\/p>\n<p>The company\u2019s recent price record also matters because the stock is now at a new yearly high for the second straight session. Readers tracking Fredun Pharmaceuticals Ltd. 52 Week High Streak should therefore keep the business profile in view alongside the valuation multiple, return ratios and sector comparison rather than reading the move in isolation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Fredun_Pharmaceuticals_Ltd_52_Week_High_Streak\"><\/span><strong>What is Fredun Pharmaceuticals Ltd. 52 Week High Streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Fredun Pharmaceuticals Ltd. 52 Week High Streak means the stock has set a fresh 52-week high on consecutive trading sessions. In this case, the streak has reached a second straight session, with the latest peak at Rs 1,730.8.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"For_how_many_sessions_has_Fredun_Pharmaceuticals_Ltd_set_a_fresh_52-week_high\"><\/span><strong>For how many sessions has Fredun Pharmaceuticals Ltd. set a fresh 52-week high?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Fredun Pharmaceuticals Ltd. has set a fresh 52-week high for two consecutive sessions.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"By_how_much_has_Fredun_Pharmaceuticals_Ltd_moved_across_the_streak\"><\/span><strong>By how much has Fredun Pharmaceuticals Ltd. moved across the streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The cumulative move across the Fredun Pharmaceuticals Ltd. 52 Week High Streak is 5.14%. That figure captures the full streak movement, not just the latest intraday change.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_52-week_high_for_Fredun_Pharmaceuticals_Ltd\"><\/span><strong>What is the latest 52-week high for Fredun Pharmaceuticals Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The latest 52-week high is Rs 1,730.8. The stock also touched that level during the current session, making it the fresh peak for the second straight trading day.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Fredun_Pharmaceuticals_Ltd_trade_relative_to_the_previous_close\"><\/span><strong>How did Fredun Pharmaceuticals Ltd. trade relative to the previous close?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock last traded at Rs 1,718.3 versus the previous close of Rs 1,707.7. That is a gain of Rs 10.6, or 0.62%, from the prior session\u2019s settled level.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_there_a_confirmed_company-specific_catalyst_for_the_repeated_highs\"><\/span><strong>Is there a confirmed company-specific catalyst for the repeated highs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> No confirmed company-specific catalyst is established by the price data alone. The numbers confirm a repeated-high pattern, but they do not explain why the stock is continuing to print new yearly highs.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_Fredun_Pharmaceuticals_Ltd_valued_after_the_streak\"><\/span><strong>How is Fredun Pharmaceuticals Ltd. valued after the streak?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Fredun Pharmaceuticals Ltd. trades at a P\/E of 55.22 and a P\/B of 8.44. Those multiples are higher than the same-industry medians in the snapshot, so the streak has left valuation in a richer zone.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_the_stock_compare_with_its_industry_medians\"><\/span><strong>How does the stock compare with its industry medians?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The stock\u2019s P\/E, P\/B, ROE and ROCE can be compared with the same-industry medians. Fredun Pharmaceuticals Ltd. stands above the median on return ratios, but it also trades above the median on valuation.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What is Fredun Pharmaceuticals Ltd. 52 Week High Streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Fredun Pharmaceuticals Ltd. 52 Week High Streak means the stock has set a fresh 52-week high on consecutive trading sessions. In this case, the streak has reached a second straight session, with the latest peak at Rs 1,730.8.\"}},{\"@type\":\"Question\",\"name\":\"For how many sessions has Fredun Pharmaceuticals Ltd. set a fresh 52-week high?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Fredun Pharmaceuticals Ltd. has set a fresh 52-week high for two consecutive sessions. The current streak label is second straight session, which means the one-year high has been reset on back-to-back trading days.\"}},{\"@type\":\"Question\",\"name\":\"By how much has Fredun Pharmaceuticals Ltd. moved across the streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The cumulative move across the Fredun Pharmaceuticals Ltd. 52 Week High Streak is 5.14%. That figure captures the full streak movement, not just the latest intraday change.\"}},{\"@type\":\"Question\",\"name\":\"What is the latest 52-week high for Fredun Pharmaceuticals Ltd.?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The latest 52-week high is Rs 1,730.8. The stock also touched that level during the current session, making it the fresh peak for the second straight trading day.\"}},{\"@type\":\"Question\",\"name\":\"How did Fredun Pharmaceuticals Ltd. trade relative to the previous close?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock last traded at Rs 1,718.3 versus the previous close of Rs 1,707.7. That is a gain of Rs 10.6, or 0.62%, from the prior session\u2019s settled level.\"}},{\"@type\":\"Question\",\"name\":\"Is there a confirmed company-specific catalyst for the repeated highs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"No confirmed company-specific catalyst is established by the price data alone. The numbers confirm a repeated-high pattern, but they do not explain why the stock is continuing to print new yearly highs.\"}},{\"@type\":\"Question\",\"name\":\"How is Fredun Pharmaceuticals Ltd. valued after the streak?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Fredun Pharmaceuticals Ltd. trades at a P\/E of 55.22 and a P\/B of 8.44. Those multiples are higher than the same-industry medians in the snapshot, so the streak has left valuation in a richer zone.\"}},{\"@type\":\"Question\",\"name\":\"How does the stock compare with its industry medians?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The stock\u2019s P\/E, P\/B, ROE and ROCE can be compared with the same-industry medians. Fredun Pharmaceuticals Ltd. stands above the median on return ratios, but it also trades above the median on valuation.\"}}]}<\/script><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Track_Fredun_Pharmaceuticals_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Fredun Pharmaceuticals Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/fredun\/fredun-pharmaceuticals-ltd-share-price-today\">Fredun Pharmaceuticals Ltd. (FREDUN) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Follow Fredun Pharmaceuticals Ltd. 52 Week High Streak alongside live price updates, valuation metrics and sector comparison on Univest. The stock page brings the latest share price, market capitalisation and key ratios into one place, which makes it easier to monitor how the repeated yearly highs evolve from here.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Fredun Pharmaceuticals Ltd. Share Price hit a fresh 52-week high of Rs 1,730.80 today and is trading at Rs 1,718.30, up 0.62% on the day. Market cap stands at Rs 2,798.83 crore.<\/p>\n","protected":false},"author":35,"featured_media":356176,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-356177","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["356176"],"rank_math_title":["Fredun Pharmaceuticals Ltd. 52 Week High Streak: Analysis"],"rank_math_description":["Fredun Pharmaceuticals Ltd. 52 Week High Streak: Fredun Pharmaceuticals Ltd. has set a fresh 52-week high for a second straight session, with cumulative gains,"],"rank_math_focus_keyword":["Fredun Pharmaceuticals Ltd. 52 Week High Streak"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/Fredun_Pharmaceuticals_Ltd_FREDUN_52_Week_High_Streak_Second_Straight_Session_bullish.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/356177","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=356177"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/356177\/revisions"}],"predecessor-version":[{"id":356178,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/356177\/revisions\/356178"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/356176"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=356177"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=356177"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=356177"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}